Evidence map›Paper›PMID 25671765›Full record

ArticleKidney international2015

Smaller caliber renal arteries are a novel feature of uromodulin-associated kidney disease.

Aleksander Prejbisz, Lorenz Sellin, Elżbieta Szwench-Pietrasz, Magdalena Woznowski, Ilona Michałowska, Dirk Blondin, Dariusz Sajnaga, Jorg T Epplen, Mieczysław Litwin, Gabriele Dekomien and 7 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Kidney international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 2 countries.

Aleksander PrejbiszDepartment of Hypertension, Institute of Cardiology, Warsaw, Poland.
Lorenz SellinDepartment of Nephrology, Medical School, Heinrich Heine University, University Hospital Duesseldorf, Duesseldorf, Germany.
Elżbieta Szwench-PietraszDepartment of Hypertension, Institute of Cardiology, Warsaw, Poland.
Magdalena WoznowskiDepartment of Nephrology, Medical School, Heinrich Heine University, University Hospital Duesseldorf, Duesseldorf, Germany.
Ilona MichałowskaDepartment of Radiology, Institute of Cardiology, Warsaw, Poland.
Dirk BlondinDepartment of Radiology, Medical School, Heinrich Heine University, Duesseldorf, Germany.
Dariusz SajnagaDepartment of Cardiology, Railway Hospital, Pruszków, Poland.
Jorg T EpplenDepartment of Human Genetics, Ruhr University Bochum, Bochum, Germany.
Mieczysław LitwinDepartment of Nephrology and Arterial Hypertension, Department of Research, Children's Memorial Health Institute, Warsaw, Poland.
Gabriele DekomienDepartment of Human Genetics, Ruhr University Bochum, Bochum, Germany.
Magdalena Januszewicz1st Department of Radiology, Medical University of Warsaw, Warsaw, Poland.
Udo HelmchenNierenregister Hamburg, Department of Pathology, University Hospital Eppendorf, Hamburg, Germany.
Joanna Matuszkiewicz-RowińskaDepartment of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
Marcin AdamczakDepartment of Nephrology, Endocrinology and Metabolic Diseases, Medical University of Silesia, Katowice, Poland.
Andrzej WięcekDepartment of Nephrology, Endocrinology and Metabolic Diseases, Medical University of Silesia, Katowice, Poland.
Andrzej JanuszewiczDepartment of Hypertension, Institute of Cardiology, Warsaw, Poland.
Lars C RumpDepartment of Nephrology, Medical School, Heinrich Heine University, University Hospital Duesseldorf, Duesseldorf, Germany.
Institute of Cardiology · PLDüsseldorf University Hospital · DEMedical University of Silesia · PLMedical University of Warsaw · PLRuhr University Bochum · DEChildren's Memorial Health Institute · PLHeinrich Heine University Düsseldorf · DEInstytut Kolejnictwa · PLUniversität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperuricemia is very common in industrialized countries and known to promote vascular smooth muscle cell proliferation. Juvenile hyperuricemia is a hallmark of uromodulin-associated kidney disease characterized by progressive interstitial renal fibrosis leading to end-stage renal disease within decades. Here we describe a member of a Polish-German family with a history of familial background of chronic kidney disease, hyperuricemia, and gout. This patient had hypertension because of bilateral small renal arteries, hyperuricemia, and chronic kidney disease. Clinical and molecular studies were subsequently performed in 39 family members, which included a physical examination, Duplex ultrasound of the kidneys, laboratory tests for renal function, and urine analysis. In eight family members contrast-enhanced renal artery imaging by computed tomography-angiography or magnetic resonance imaging was conducted and showed that bilateral non-arteriosclerotic small caliber renal arteries were associated with hyperuricemia and chronic kidney disease. Of the 26 family members who underwent genotyping, 11 possessed the P236R mutation (c.707C>G) of the uromodulin gene. All family members with a small caliber renal artery carried the uromodulin P236R mutation. Statistical analysis showed a strong correlation between reduced renal artery lumen and decreased estimated glomerular filtration rate. Thus, bilateral small caliber renal arteries are a new clinical phenotype associated with an uromodulin mutation.

Indexed as

Glomerular Filtration RateAdolescentAdultAgedAngiographyChildChronic DiseaseFemaleGenotypeGoutHumansHyperuricemiaKidney DiseasesKidney Failure, ChronicKidney Tubules, DistalMaleUric AcidUromodulin

Identifiers

PMID25671765
OpenAlexW2028138510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.